Cancer Stem Cells May Hold the Key to Understanding Drug Resistance
Understanding the signaling pathways of cancer stem cells could hold promise for treating resistant forms of cancer.
Understanding the signaling pathways of cancer stem cells could hold promise for treating resistant forms of cancer.
As our aging workforce expands, a decreasing number of young investigators are applying for National Institute of Health (NIH) R01-equivalent grants.
Access to chemotherapy is just 1 of many factors influencing disparities of survival rates among men and women diagnosed with bladder cancer.
A combination of radiotherapy with local and systemic immunotherapy may be clinically beneficial for treating some types of tumors.
ASCO states that it supports Congress, the Obama Administration, and multiple federal agencies in their efforts to prevent and respond to prescription drug abuse.
Durvalumab may be an effective treatment option for programmed cell death ligand-1 (PD-L1)-positive patients with urothelial bladder cancer (UBC).
Poor OS in women with bladder cancer may be attributable to the lower frequency of women being treated with systemic chemotherapy.
Clinicians seek stronger collaboration between cardiology and oncology as well as evidence-based treatment guidelines.
Prostate cancer patients who undergo radiation treatment, especially brachytherapy, are at increased relative risk of bladder cancer.
Cytoreductive radical cystectomy may be beneficial for select patients with metastatic urothelial carcinoma of the bladder.